The Department of Nephrology consists of the Nephrology ward, the Haemodialysis and Peritoneal Dialysis units and the Nephrology Outpatient Clinics.
The Nephrology ward is located on the 3rd floor of the Limassol General Hospital and operates with a capacity of 12 inpatient beds and 4 dialysis beds, accommodating inpatients that require specialised treatment or dialysis, respectively.
The Haemodialysis unit which is located on the ground floor, facilitates 34 haemodialysis stations where patients can have their regular dialysis sessions. The department holds three dialysis sessions a day, seven days a week. It also serves patients from abroad, visiting our island for either business or leisure. Citizens of the European Union are entitled to free medical care given they hold a valid European medical card. Visitors from abroad who intend to visit the department are encouraged to contact us three months in advance for their convenience.
The Peritoneal Dialysis unit normally serves patients undergoing Peritoneal dialysis at home. The unit’s main activities include training of patients by specialised staff and providing information on existing methods of peritoneal dialysis.
Patients with various nephrological conditions can be referred to the Nephrology Outpatient Clinics by their attending physician. The clinic operates and accepts visits daily. The clinic provides full specialisation and training in Clinical Nephrology for medical students of the University of Nicosia and St. George’s University.
Research papers
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction
2023 Autoimmunity Rev_IBD and GN
Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
2023 BMC Genomics_Gene expression monocytes SLE
Sodium bicarbonate in kidney transplant recipients: do some apples a day keep the doctor away?
2023 Clin Kidney J_Sodium bicarbonate in Tx
Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations
2023 Nephrol Dial Transplant_Management of vasculitis
Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)
2023 Nephrol Dial Transplant_Vaccination
Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al
2024 Ann Rheum Dis_Correspondence on EULAR recommendations
AA Amyloidosis: A Contemporary View
2024 Curr Rheumatol Rep_AA Amyloidosis
Immunosuppression Withdrawal in Patients with Lupus Nephritis
2024 JASN_Immunosuppression withdrawal in LN
EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association–Immunonephrology Working Group (ERA-IWG) perspective
2024 Nephrol Dial Transplant_EULAR recommendations for LN
Immunoengineering for autoimmune-kidney disease
2024 Nephrol Dial Transplant_Immunoengineering
Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group
2024 Nephrol Dial Transplant_Management of podocytopathies
Malignancies and glomerulonephritis: when to suspect and when to screen?
2025 Clin Kidney J_Malignancies in GN
Quo Vadis Standardization of Anti-Nephrin Antibody Detection?
2025 Glom Dis_Anti-nephrin
Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication
2025 Kidney Intern_Sex dymorphism
Antibody-mediated podocytopathies: a disease entity that implies immunotherapy
2025 Nephrol Dial Transplant_Antibody-mediated podocytopathies
Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)
2025 Nephrol Dial Transplant_DMANDs
Complement activation in secondary thrombotic microangiopathies
2025 Nephrol Dial Transplant_Complement inhibition in secTMA
Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome
2023 Front Cell Dev Biol_Spheroids Alport
Appointments and Information
